Global Metagenomics Sequencing Market Analysis & Forecast to 2024-2034

The global metagenomics sequencing market size was estimated to be USD 2.34 billion in 2023 and is expected to reach at USD 14.25 billion by 2034 with a CAGR of 17.85% during the forecast period 2024-2034. Increasing technological innovations in Next Generation Sequencing (NGS) platforms, growing prevalence of genetic disorders, rising funding by government & private bodies for large-scale sequencing projects, surge in research & development activities, increasing funding from government and private bodies for large-scale sequencing, and growing technological development are some of the key factors boosting the market growth.

Growing technological development is predicted to boost the market growth during the forecast period. Continuous technological progress in sequencer technology has enabled the creation of efficient, portable, and user-friendly NGS platforms capable of providing rapid, precise results with quicker processing times. Prominent companies are dedicating more resources to research and development to enhance their market standing and market share, recognizing that the introduction of such products and technologies provides an instant advantage over competitors. For instance, in March 2022, Thermo Fisher Scientific has introduced the Ion Torrent Genexus Dx Integrated Sequencer, which is an automated platform for next-generation sequencing (NGS).

By product, reagents & consumables was the highest revenue-grossing segment in the global metagenomics sequencing market in 2023 owing to the rising use of reagents and consumables guarantees that the DNA used for metagenomics sequencing analysis is representative of all cells present in the sample and suitable for creating genomic libraries, growing genetic disorders, increasing metagenomics sequencing research projects, and surge in launch of advanced systems. For instance, in September 2022, Illumina, Inc. (US) has unveiled the NovaSeq X series production-scale sequencers, which have the capacity to produce over 20,000 whole genomes annually, marking a throughput increase of 2.5 times compared to previous Illumina sequencers. Additionally, services is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of analysis & data interpretation solution platforms and surge in technological advancements.

By technology, 16S rRNA sequencing was the highest revenue-grossing segment in the global metagenomics sequencing market in 2023 owing to the advantages include excellent precision as well as affordability and rising initiatives by major market players. For instance, in June 2023, Zymo Research, a prominent supplier of microbiology research tools, has formally introduced its Full-Length 16S Sequencing Service. This service provides researchers with top-tier, complete 16S rRNA gene sequencing for microbiome analysis. Additionally, shotgun metagenomics sequencing is predicted to grow at fastest CAGR during the forecast period owing to the benefits of shotgun sequencing over alternative sequencing methods, and growing number of metagenomics sequencing-based research activities.

By workflow, sample preparation was the highest revenue-grossing segment in the global metagenomics sequencing market in 2023 owing to the tools for cutting-edge sample processing and library preparation are readily available and surge in number of metagenome sequencing research projects. Additionally, Data Processing & Analysis is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and increasing launch of advanced systems. For instance, in April 2023, Pattern Ag manages the largest metagenomics database dedicated to soil globally, utilizing data from over 43 Terabases of soil information. This database surpasses the size and importance of the publicly accessible Tara Oceans database, which was developed through a five-year multinational academic collaboration. Pattern Ag is continually expanding its own database with additional information.

By application, drug discovery was the highest revenue-grossing segment in the global metagenomics sequencing market in 2023 owing to the surge in research & development activities, increasing prevalence of chronic diseases, and rising funding from government and private bodies. For instance, in October 2022, The Chan Zuckerberg Initiative (CZI) has disclosed a $2 million grant from the Bill & Melinda Gates Foundation aimed at advancing research in the field of new and emerging diseases. In collaboration, CZI and the Gates Foundation plan to provide grants of up to $200,000 each to ten new recipients, with the goal of improving their access to NGS (Next-Generation Sequencing) and other technologies for metagenomics research in countries with moderate to low incomes. The grant recipients will also receive training in sequencing, bioinformatics, and data analysis, along with personalized technical support for the Chan Zuckerberg ID cloud-based metagenomics sequencing platform. Additionally, clinical diagnostic is predicted to grow at fastest CAGR during the forecast period owing to growing focus on development of software packages & instruments utilized in the metagenomics studies, increasing prevalence of pathogenic & viral diseases

North America region is anticipated for the highest revenue share during the forecast period owing to the increasing applications of metagenomics in genomics & diagnostics research, rising funding for research activities, growing focus on development of NGS data analysis tools, and surge in initiaitves by leading market players. For instance, in May 2023, CD Genomics, a genomics services company headquartered in the United States, has introduced the Long-Read Metagenomic Sequencing service. This advanced technology empowers researchers and scientists to gain a deeper and more accurate understanding of the intricacies within microbial communities. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing implementation of DNA sequencing across metagenomics applications, increasing adoption of novel sequencing technologies, surge in research & development activities, and rising demand for advanced solutions. For instance, in November 2022, PerkinElmer has expedited gene therapy research by introducing an industry-first, pre-prepared viral vector assay.

Segmentation: Metagenomics Sequencing Market Report 2023 - 2034

Metagenomics Sequencing Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)

• Instruments
• Reagents & Consumables
• Services
• Metagenomics Sequencing Services
• Analysis & Data Interpretation Solutions

Metagenomics Sequencing Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)

• Shotgun Metagenomic Sequencing
• 16S rRNA Sequencing
• Metatranscriptomics
• Whole-Genome Sequencing & De Novo Assembly

Metagenomics Sequencing Market Analysis & Forecast by Workflow 2023 - 2034 (Revenue USD Bn)

• Sequencing
• Data Processing & Analysis
• Sample Preparation

Metagenomics Sequencing Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

• Clinical Diagnostics
• Drug Discovery
• Biofuel
• Industrial Application
• Ecological & Environmental Metagenomics

Metagenomics Sequencing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
• Middle East & Africa
• South Africa
• GCC
• Rest of MEA